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Death receptors (DRs) and their ligands are expressed in developing nervous system. However, neurons are generally resistant to death
induction through DRs and rather their activation promotes neuronal outgrowth and branching. These results suppose the existence of
DRs antagonists expressed in the nervous system. Fas apoptosis inhibitory molecule (FAIMS) was first identified as a Fas antagonist in
B-cells. Soon after, a longer alternative spliced isoform with unknown function was identified and named FAIML. FAIMS is widely
expressed, including the nervous system, and we have shown previously that it promotes neuronal differentiation but it is not an
anti-apoptotic molecule in this system. Here, we demonstrate that FAIML is expressed specifically in neurons, and its expression is
regulated during the development. Expression could be induced by NGF through the extracellular regulated kinase pathway in PC12
(pheochromocytoma cell line) cells. Contrary to FAIMS, FAIML does not increase the neurite outgrowth induced by neurotrophins and
does not interfere with nuclear factor B pathway activation as FAIMS does. Cells overexpressing FAIML are resistant to apoptotic cell
death induced byDRs such as Fas or tumor necrosis factor R1. Reduction of endogenous expression by small interfering RNA shows that
endogenousFAIMLprotectsprimaryneurons fromDR-inducedcell death.Thedetailedanalysis of this antagonismshows thatFAIMLcan
bind to Fas receptor and prevent the activation of the initiator caspase-8 induced by Fas. In conclusion, our results indicate that FAIML
could be responsible formaintaining initiator caspases inactive after receptor engagement protecting neurons from the cytotoxic action
of death ligands.
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Introduction
Death receptors (DRs) and their ligands are expressed in the
nervous system, particularly during development (Park et al.,
1998; Neumann et al., 2002; Shin et al., 2002; Choi and Ben-
veniste, 2004). However, they do not seem to play a major role
regulating physiological neuronal death except in certain popu-
lations such as the motoneurons (Raoul et al., 1999, 2000, 2002).
The activation of DRs can alternatively induce cell survival or
differentiation through the nuclear factor B (NF-B) or the
extracellular-regulated kinase (ERK) signaling pathways (Des-
barats et al., 2003; Marchetti et al., 2004). In this way, DRs could
regulate neuronal plasticity during the development of the ner-
vous system (Cheema et al., 1999; Martin-Villalba et al., 1999;
Desbarats et al., 2003; Zuliani et al., 2006). They were also in-
volved in pathological neuronal death: Fas in spinal cord injury
(Demjen et al., 2004; Yoshino et al., 2004; Casha et al., 2005;
Ackery et al., 2006), or Fas and tumor necrosis factor (TNF) in
axotomy-induced motoneuron death (Ugolini et al., 2003) and
ischemia-induced brain damage (Martin-Villalba et al., 1999,
2001; Graham et al., 2004)
DR activity can be regulated (blocked) by anti-apoptotic pro-
teins such as c-FLIP (FLICE-inhibitory protein), C-IAP-1/2 (cel-
lular inhibitor of apoptosis-1/2), or the anti-apoptotic members
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of the Bcl-2 family (Liston et al., 1997; Tschopp et al., 1998;
Desagher and Martinou, 2000). However, emerging evidence
shows that other DR-regulatory molecules are expressed in the
nervous system, such as Lifeguard (LFG) or PEA-15 (phospho-
protein enriched in astrocytes-15 kDa) (Boldin et al., 1995; Somia
et al., 1999; Ferna´ndez et al., 2007).
Fas apoptosis inhibitory molecule (FAIM) was characterized
as an inhibitor of Fas that was upregulated in B-cells resistant to
Fas-mediated cell death (Schneider et al., 1999). Later, an alter-
native spliced form containing 22 aa longer at theN terminus was
reported and named FAIM long (FAIML) (Zhong et al., 2001).
FAIMS is widely expressed, whereas FAIML is almost exclusively
expressed in the nervous system. We reported previously that
FAIMS, but not FAIML, overexpression greatly enhances neurite
outgrowth in PC12 (pheochromocytoma cell line) cells and pri-
mary neurons through theNF-B andmitogen-activated protein
kinase (MAPK)/ERK pathways (Sole et al., 2004). Nonetheless,
the physiological role of FAIML remains so far to be elucidated.
Here, we provide for the first time evidence that FAIML in vivo
is highly expressed by neurons in diverse areas of the brain.More-
over, FAIML levels are regulated during neuronal differentiation,
both in vivo and in vitro, and the ERK pathway seems to be an
important regulator of its expression after NGF stimulation. Ec-
topically overexpressed FAIML blocks Fas and TNF-induced cell
death in both PC12 cells and cortical neurons. Specific knock-
down of endogenous FAIML transcript renders PC12 cells and
primary neurons (cortical neurons and motoneurons) sensitive
to the proapoptotic action of FasL and TNF-. FAIML, but not
FAIMS, is able to bind nonstimulated Fas in coimmunoprecipi-
tation experiments. Binding could be displaced by FAS-
associated death domain (FADD) overexpression, indicating that
FAIML and FADD compete for Fas binding. When Fas is stimu-
lated by FasL, the interaction between Fas and FAIML is no longer
observed. Altogether, our results place FAIML as a novel endog-
enous antagonist regulating DR-mediated neuronal cell death.
Materials andMethods
Reagents. Purified recombinant human NGF was obtained from Genen-
tech (San Francisco, CA), and mouse 7S NGF was prepared from male
submandibular salivary glands as described previously (Mobley et al.,
1976). Anti-phospho-ERK1/2 was obtained from Cell Signaling Tech-
nology (Beverly, MA). Anti-pan-ERK was obtained from BD Transduc-
tion Laboratories (San Diego, CA). Anti-FLAG M2, apoptosis-inducing
factor (AIF), and -tubulin were obtained from Sigma (St. Louis, MO).
Anti- histoneH1was obtained fromStressgen (AnnArbor,MI). Anti-Fas
was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). A rabbit
polyclonal anti-FAIM antibody was characterized previously in our lab-
oratory (Sole et al., 2004). All biochemicals were obtained from Sigma-
Aldrich unless otherwise indicated.
Cell culture. PC12 cells were cultured in DMEM supplemented with
6% heat-inactivated fetal calf serum, 6% heat-inactivated horse serum
(HS) (Invitrogen, Paisley,UK), 10mMHEPES, 20U/ml penicillin, and 20
g/ml streptomycin.
Primary cortical neurons were dissected from embryonic day 16 (E16)
mice (unless otherwise indicated) and cultured as described previously
(Iglesias et al., 2003). Cells were plated in 10 g/ml poly-D-lysine-coated
culture plates and cultured in DMEM supplemented with 10%HS. After
4 h, medium was replaced with serum-free DMEM supplemented with
B27 (Invitrogen) and N2 (Invitrogen).
Spinal cord motoneurons (MTNs) were purified from E12.5 mice
according to Arce et al. (1998) and Comella et al. (1994), with minor
modifications. Briefly, spinal cords were dissected from mouse embryo,
trypsinized (Sigma) for 7 min at 37°C, and dissociated and collected
under a bovine serum albumin (BSA) cushion. The MTNs were then
isolated byOptiPrep density gradient centrifugation (10min at 520 g).
After a final centrifugation through a BSA cushion, MTNs were resus-
pended in neurobasalmedium supplementedwith 2%horse serum, B27,
0.5 mM L-glutamine, 25 M 2-mercaptoetanol, and 10 ng/ml BDNF
(Alomone Labs, Jerusalem, Israel) and plated in poly-ornithine/laminin-
coated four-well plates (Nunc, Rochester, NY) at a density of 5  103-
1 104 cells per well. All cultures weremaintained at 37°C in a saturated
humidified atmosphere of 95% air and 5% CO2.
Anti-FAIML antibody production. A rabbit polyclonal antibody was
generated according to standard protocols (Harlow, 1988). The immu-
nogenic peptide used was SGDDSPIFEDDESPLC (amino acids 3–18)
and corresponds to a part of the differential sequence between FAIML
and FAIMS isoforms.
Plasmids. Rat FAIML was expressed under the control of a cytomega-
lovirus constitutive promoter in the pcDNA3 expression vector (Invitro-
gen) as described previously (Sole et al., 2004). cDNAs containing ORFs
of FADD, and murine Fas were subcloned into a vector holding a
C-terminal hemaglutinin epitope (HA) or pcDNA3, respectively.
For RNA interference (RNAi) experiments, constructs were obtained
into the pSUPER.retro.puro plasmid (OligoEngine, Seattle, WA) using
specific oligonucleotides of the FAIM sequence, indicated by capital let-
ter, as follows, RNAi n°1, which is specific for FAIML (forward), gatc-
cccGATGTTCAAATTGGTGGGCttcaagagaGCCCACCAATTTGAA-
CATCttttt, and (reverse) agctaaaaaGATGTTCAAATTGGT-
GGGCtctcttgaaGCCCACCAATTTGAACATCggg. RNAi n°2, which
is specific for FAIMS (forward), gatccccGGCAAACGAGTTGTG-
TACGttcaagagaCGTACACAACTCGTTTGCCttttt, (reverse) agcta-
aaaaGGCAAACGAGTTGTGTACGtctcttgaaCGTACACAACTCGTT-
TGCCggg. Oligonucleotides were obtained from Sigma and were
cloned between BglII/HindIII sites of pSUPER.retro.puro plasmid.
Lentiviral constructs were achieved by digesting EcoR1-ClaI sites
from pSUPER-sh to replace H1 promoter with H1-shRNA cassette in
pLVTHM.
Production of lentiviral particle. Lentiviruses were propagated using
methods described previously (Naldini et al., 1996; Zufferey et al., 1998).
Briefly, human embryonic kidney 293T (HEK293T) cells were seeded at
a density of 2.5  106 cells in 0.1% gelatin-coated 100 mm dishes. The
following day, cells were transfected with 20 g of pLVTHM or pWPI
derived constructs, 13 g of pSPAX2, and 7 g of pM2G. The transfec-
tion was routinely performed by the calcium phosphate transfection
method (Cullen, 1987). Cells were allowed to produce lentiviruses for
48 h. After 48 h, the medium was centrifuged at 1200 g for 5 min, and
the supernatant was filtered using 45 m filters. Lentiviruses were con-
centrated at 50,000 g for 90 min and then resuspended in 20l of PBS
containing 1% BSA. Lentiviruses were stored at80°C. Biological titers
of the viral preparations expressed as a number of transducing units per
milliliter (TU/ml) were determined by transducing HEK293T cells in
limiting dilutions. After 48 h of incubation, the percentage of green flu-
orescent protein (GFP)-positive cells was counted and viruses at 5 
108-1 109 TU/ml were used in the experiments.
Cell transfection and transduction. Unless otherwise indicated, PC12
cells were transfected with the desired expression plasmid using Lipo-
fectamine 2000 (Invitrogen) according to suggested manufacturer pro-
cedures. Pools of cells transfected with FAIML, FAIMS, or empty
pcDNA3 were obtained by adding 500 g/ml G418 (Geneticin) to the
culture medium (Invitrogen).
For lentiviral-based knock-down experiments, cells were seeded in
24-multiwell plates at a density of 2 104 cells/well for PC12 cells, 1
105 for cortical neurons, or 5–10 103 for MTNs. Concentrated lenti-
viruses were added to the medium (minimum multiplicity of infection,
5). After 4 h, the medium was changed and the infection efficiency was
monitored in each experiment by direct counting of GFP-positive cells.
The percentage of infection reached to 80% for cortical neurons [3 d in
vitro (DIV)] and MTNs (5DIV) and 99% for PC12 cells.
Western blot analysis. Cells were rinsed in ice-cold PBS, pH 7.2, after
stimulation. Cell lysate was harvested with 2% SDS-125 mM Tris/HCl,
pH 6.8, and protein concentration was quantified by a modified Lowry
assay (Bio-RadDc protein assay; Bio-Rad, Hercules, CA). Cell lysates
(10–25 g of protein) were resolved in SDS-PAGE and transferred onto
polyvinylidene difluoride (PVDF) Immobilon-Pmembranes (Millipore,
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Bedford, MA) using a semidry transfer unit (Hoefer Pharmacia Biotech,
San Francisco, CA). After blocking with Tris-buffered saline with
Tween-20 containing 5% nonfat dry milk for 1 h at room temperature,
the membranes were probed with the appropriate primary antibodies
according to the specific requirements indicated by each provider. After
1 h of incubation with the specific peroxidase-conjugated secondary an-
tibodies, the membranes were developed with the EZ-ECL chemilumi-
nescence detection kit (Biological Industries, Kibbutz Beit Haemek,
Israel).
Reverse transcription-PCR analysis. Reverse transcription (RT)-PCR
was essentially performed using standard protocols (Bayascas et al.,
2004). Briefly, cDNA was reverse-transcribed from RNA of adult mice
tissues and PC12 cells with the RNeasy kit according to themanufactured
instructions (Qiagen, Valencia, CA). PCR was performed by amplifica-
tion of FAIML, FAIMS, and the housekeeping L27 ribosomal protein
cDNAs in a PerkinElmer (Emeryville, CA) thermal cycler 2400. Primers
used to amplify 189 and 246 bp specific fragments corresponding to
FAIMS and FAIML, respectively, were: GACAGCTGCTGACTACGTCG
(forward) and TCCTTCCCATCCACGTACAC (reverse). Primers used
to specifically amplify the 246 bp fragment corresponding to FAIML
were: CGGGATCCCTGGCGTCTGGAGATGACAGT (forward) and
TCCTTCCCATCCACGTACAC (reverse). L27 primers were: AGCTGT-
CATCGTGAAGAA (forward) and CTTGGCGATCTTCTTCTTGCC
(reverse).
Immunofluorescence. E15 cortical neurons at 1 DIV were transfected
with pcDNA3-FAIML using Lipofectamine 2000 (Invitrogen) with the
desired constructs and 48 h later were rinsed with PBS at room temper-
ature and fixed in 4% paraformaldehyde/PBS for 30 min at room tem-
perature. Then, they were washed twice with PBS and subsequently per-
meabilized and blockedwith 5%bovine serum albumin and 0.1%Triton
X-100 in PBS for 60 min at room temperature. The cells were incubated
overnight withmonoclonal anti-FLAG, rinsed three times with PBS, and
incubated with anti-rabbit secondary antibodies conjugated with Alexa
Fluor 488 (Invitrogen, Eugene OR) for 1 h at room temperature pro-
tected from light. Confocalmicrographs were obtained using an inverted
Olympus XT FV500 microscope (Olympus Optical, Tokyo, Japan).
For the active caspase-3 immunofluorescence, cells were fixed and
permeabilized as indicated above and then incubated overnight at 4°C
with a polyclonal anti-cleaved Caspase-3 (Cell Signaling Technology)
diluted 1:150, rinsed three times with PBS, and incubated with anti-
rabbit secondary antibodies conjugated with Alexa Fluor 594 (Invitro-
gen) diluted 1:250 for 1 h at room temperature protected from light.
Finally, cells were stained with 0.05 g/ml Hoechst 33258 for 30 min.
Representative micrographs were obtained using an inverted Olympus
XT.
Immunohistochemistry. E16, E18, postnatal day 0 (P0), P5, P10, and
adult (P60) OF-1 mice (Charles River, Lyon, France) were used for the
immunohistochemistry experiments. The day when the vaginal plug was
detected was considered E0 and the day of birth as P0. First, the animals
were deeply anesthetized with a mixture of Ketolar (Parke-Davies/Pfizer
New York, NY)/Rompun (Bayer, Leverkusen, Germany) and perfused
with 4% paraformaldehyde. The brains were removed, cryoprotected,
and frozen. Thirty to 50mcoronal sections were obtained. After block-
ing, sections were incubated overnight with specific rabbit antibody
against FAIML (1:600). This primary antibody was visualized by sequen-
tial incubation with biotinylated secondary antibodies (1:200; Vector
Laboratories, Burlingame, CA) and the streptavidine-peroxidase com-
plex (1:400; Amersham Biosciences, Pittsburgh, PA). The peroxidase re-
action was developed with diaminobenzidine and H2O2. Sections were
mounted onto gelatinized slides, dehydrated, and coverslippedwithDPX
(a mixture of distyrene, tricresyl phosphate, and xylene).
Sections from E16, P5, and adult mice were used for double immuno-
fluorescence studies. After blocking, sections were incubated overnight
with the specific rabbit antibody detecting FAIML (1:600) combinedwith
mouse monoclonal antibodies against neuronal-specific nuclear protein
(NeuN) (1:100; Chemicon, Temecula, CA), calbindin, or parvalbumin
(Calb 1:5000; Parv, 1:2000; Swant, Bellinzona, Switzerland), GFAP (1:
500; Chemicon), or with a rat monoclonal antibody against CD31 (1:10;
BD PharMingen, San Diego, CA). Primary antibodies were visualized
using secondary Alexa Fluor-conjugated antibodies. Sections were coun-
terstained with Bisbenzimide, mounted onto slides, and viewed under
confocal microscopy. Some sections were also incubated with preim-
mune serum (1:600) and processed as above.
FAIM promoter assay. The predicted promoter of FAIMwas amplified
from rat genomic DNA using the primers 5-TCCCCCGGGCTC-
TGCCAAACACCCTGATTTG-3 (forward) and 5-CCGCTCGAGCC-
CAGCCTCCTACTGCCTTCC-3 (reverse). The amplified fragment
(2.2 kbp) was subcloned into pGL3-basic (Promega, Mannheim, Ger-
many). For the assay, PC12 cells were seeded into 24-well plates and
transfected with the pGL3-empty or pGL3–2.2 kbp vectors. Twenty-four
hours later, cells were treated as indicated. After an additional 24 h, cells
were lysed with the Cell Culture Lysis Reagent (Luciferase Assay System
Kit; Promega). The activity of firefly luciferase was determined using a
FB12 Luminometer (Berthold, Bundoora, Australia). Aliquots of super-
natant were transferred to a standard 96-well plate for protein concen-
tration determination by the Lowry method (Bio-Rad) following the
manufacturer instructions. Luciferase values were normalized in respect
to protein concentration (RLU/g of protein).
Assessment of cell survival and apoptotic cell death. A total of 1  106
PC12 cells were infectedwith lentivirus carrying indicated constructs and
48 h later were split in 24-well plates (2  104 cells/well) in triplicate.
Twenty hours later, cells were treatedwith sFasL (100 ng/ml), TNF (100
ng/ml) plus 1 nM ActD for 24 h, or left untreated. For mouse primary
cultures, neurons were transduced as described above and treated with
Jo2 (5g/ml) at 3 DIV for cortical neurons and 5 DIV for motoneurons.
Apoptotic cell death was measured 24 h later by counting apoptotic
nuclei after Hoechst 33258 nuclear staining according to Yuste et al.
(2005). Experiments were repeated at least three times, and a minimum
of 500 cells were counted per condition. Apoptosis was also assessed by
TUNEL staining. To this end, cells were fixed in 4% paraformaldehyde/
PBS for 60 min at room temperature, permeabilized with 0.1% Triton
X-100 in 0.1% Sodium Citrate for 2 min at 4°C, and processed following
the In Situ Cell Death Detection Kit instructions (Roche Products, Wel-
wyn Garden City, UK). For the final step, Hoechst 33258 was added at
0.05 g/ml. The cell death was scored by counting positively stained
apoptotic nuclei using an Olympus microscope equipped with epifluo-
rescence optics. When necessary, cell viability was determined by the
alamarBlue assay following the manufacturer instructions (Biosource,
Camarillo, CA).
Fluorogenic caspase activities. Caspase activity determination was per-
formed as described previously (Yuste et al., 2001). The assays were per-
formed using 150 M fluorogenic substrate Ac-IETD-afc (caspase-8-
directed activities) or 50 M Ac-DEVD-afc (caspase-3-like activities).
The plates were read in a Bio-Tek (Izasa, Spain) FLx800 Fluorimeter
using a 360 nm (40 nmbandwidth) excitation filter and a 530 nm (25 nm
bandwidth) emission filter.
Neurite measurement. PC12 cells were infected with lentivirus RS, R1,
and R2 for 72 h and then washed and transferred to poly-D-lysine/
collagen-coated 35 mm dishes at a density of 1  105 cells per dish.
Twenty-four hours later, complete medium was replaced with medium
containing NGF (100 ng/ml) with 0.5% of horse serum. Photographs of
random fields were taken 1 d later by using an inverted microscope
(Olympus) equipped with epifluorescence optics coupled with a digital
camera (OM-4 Ti; Olympus). Neurite outgrowth was measured using
the Adobe Photoshop 6.0 software (Adobe Systems, San Jose, CA). In
every experiment, a minimum of 100 cells were measured per condition.
NF-B activity. NF-B activity was measured as described previously
(Sole et al., 2004). Briefly, PC12 cells were seeded in 24-well plates at a
density of 1  105 cells/well. Cells were transfected with 0.5 g/well of
the NF-kB-dependent reporter vector (HIV-LTR-Luciferase). Twenty
four hours later, cells were stimulated with 100 ng/ml NGF for 6 h. The
activity of firefly luciferase was determined as described above. The NF-
kB-dependent reporter vector (HIV-LTR-luciferase) was obtained from
R. Hay (University of St Andrews, Fife, Scotland).
Coimmunoprecipitation. For coimmunoprecipitation (CoIP) experi-
ments, 3  106 HEK293T cells were seeded on 150 mm tissue culture
dishes and transfected using the calcium phosphate method (Cullen,
1987) with pEYFP (Clontech), pcDNA3-FAIML-FLAG or pcDNA3-
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FAIMS-FLAG constructs. PC12 cells seeded onto 150 mm tissue culture
dishes were transfected using Lipofectamine 2000 with pEYFP (Clontech),
pcDNA3-FAIML-FLAG, pcDNA3-FAIMS-FLAG, HA-FADD, or pcDNA3-
mFas constructs. When indicated, cells were stimulated with sFasL, 24 h
posttransfection. After 2 d posttransfection, cells were harvested in lysis
buffer CoIP (20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 10%
Glycerol, 1%TritonX-100) supplementedwith aprotease inhibitormixture
(RocheDiagnostics). Lysates were clarified by centrifugation and quantified
by the Lowry assay (Bio-Rad). Onemilligram of total protein was taken and
adjusted with the CoIP buffer to achieve a final concentration of 1 g/l.
Fortymicrolitersof anti-FLAGM2-agarose-coupledantibodywereadded to
each sampleand incubatedovernight at4°C inanorbital shaker.Then,beads
werewashed five timeswithCoIPbuffer andeluted for 30minat 4°Cwith50
l of TBS containing 150 ng/ml of 3xFLAG competitor peptide (Sigma).
After a short spin, supernatantswere carefully taken, Laemli’s-loadingbuffer
was added, and SDS-PAGEwas performed.
Alternatively, 1 mg of cleared supernatant from PC12 cells was sub-
jected to immunoprecipitation with 2 g of an anti-Fas antibody over-
night at 4°C. Antibodies were recovered with protein-G and resolved in
SDS-PAGE.
Results
FAIML is a cytosolic protein predominantly expressed
in neurons
With the aim to study FAIML expression and distribution, as well
as to explore its functional role, we first developed a specific
rabbit polyclonal antibody. Because the
differential sequence between FAIMS and
FAIML is 22 aa at the N terminus of the
protein, 16 of these 22 were selected as an
antigen. To demonstrate antibody speci-
ficity, we analyzed the expression of
FAIML in lysates from brain (positive con-
trol) and liver (used as a negative control).
The antibody recognized a single immu-
noreactive band only in brain lysates with
an apparent molecular weight of23 kDa
(supplemental Fig. 1A, right panel, avail-
able at www.jneurosci.org as supplemen-
tal material) that was absent when the
membrane was blotted using the preim-
mune serum (supplemental Fig. 1A, mid-
dle panel, available at www.jneurosci.org
as supplemental material). We further
confirmed that the23 kDa band indeed
corresponds to FAIML by transient trans-
fection of HEK293T cells with increasing
amounts of N-terminally FLAG-tagged
FAIML. Duplicate samples were loaded in
a gel; one set of samples was blotted with
anti-FLAG (supplemental Fig. 1B, left
panel, available at www.jneurosci.org as
supplementalmaterial) and the other with
anti-FAIML (supplemental Fig. 1B, right
panel, available at www.jneurosci.org as
supplemental material). Both antibodies
recognize the same band with enhanced
intensity corresponding to the increasing
amounts of transfectedDNA (supplemen-
tal Fig. 1B, available at www.jneurosci.org
as supplemental material). Moreover, we
wanted to analyze whether anti-FAIML
antibodies were able to detect the protein
in nondenaturing conditions. For this
purpose, we synthesized FLAG-tagged
FAIML using an in vitro reticulocyte-based
transcription and translation system (Promega). Reticulocyte
suspensionwas subjected to immunoprecipitationusing the anti-
FAIML antibody. Immunoprecipitates were resolved on SDS-
PAGE gels and blotted with anti-FLAG. Anti-FAIML antibodies
were able to immunoprecipitate FAIML, whereas no signal was
detected using a nonrelevant rabbit immune serum (supplemen-
tal Fig. 1C, available at www.jneurosci.org as supplemental
material).
The anti-FAIML antiserum was then used to analyze the pro-
tein expression profile in different mouse tissues. An immunore-
active band of 23 kDa was detected in lysates from different
brain regions such as cortex, hippocampus, and cerebellum, as
well as in spinal cord. No signal was detected in heart, skeletal
muscle, kidney, liver, or lung (Fig. 1A). RT-PCR analysis con-
firms identical specific FAIML distribution in the nervous system
(Fig. 1B). Moreover, we analyzed the expression of FAIML in the
hematopoietic/immune system, because of the high relevance of
DRs in that system. FAIMLprotein expressionwas not detected in
cell lines or in primary lymphocytes but was detected in cerebral
cortex lysate used as a positive control. Note that FAIMS was
detected in lymphocytic cell lines (Fig. 1C).
We next examined the subcellular distribution of FAIML. For
this purpose, PC12 cells were lysed in a hypotonic buffer and
Figure 1. FAIML is expressed only in the nervous system. A, Adult mouse tissue lysates (20g) were analyzed by SDS-PAGE/
immunoblot using anti-FAIML serum (1:1000) (top panel). As the loading control, themembrane was stained with Naphtol Blue.
B, Mouse FAIML mRNA tissular content was assessed by semiquantitative RT-PCR with specific primers and compared with L27
housekeeping gene. C, Immunoblot analysis of the FAIML expression in human and mouse hematopoietic/immune cells as
indicated. Cortical neurons, neuroblastoma SH-SY5Y, and transfected PC12 extracts were used as a positive control of the FAIML
and total FAIM expression. Twenty micrograms of total protein were resolved by SDS-PAGE and blotted with anti-FAIMS (top
panel) and FAIML (middle panel). Naphtol blue staining was used as a loading control (bottom panel). D, PC12 cells were lysed in
a hypotonic solution, and two crude subcellular fractions were prepared. The equivalent protein content of each fraction was
subjected to SDS/PAGE immunoblot analysis using antibodies specific for FAIML, pan-ERK (cytosolic marker), Histone H1 (nuclear
marker), and AIF (mitochondria marker). C, Cytosolic fraction; HMN, heavy membrane and nuclear fraction. E, Subcellular
distribution of FAIML. Confocalmicroscopy (60) of E15 cortical cells transfectedwith FLAG-FAIML and immunofluorescencewith
anti-FLAG coupled to a secondary anti-mouse conjugated to FITC. Scale bar, 20m. CX, Cortex; CL, cerebellum; HP, hippocampus;
HT, heart; SM, skeletalmuscle; KD, kidney; SC, spinal cord; LV, liver; LG, lung;NB,Naphtol Blue; C, cytosolic; HM,heavymembranes;
N, nuclei.
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separated by centrifugation into two subcellular fractions, one
containing only cytosolic proteins (C) and the other including
heavy membranes and nuclei (HMN). FAIML was only de-
tected in the cytosolic fraction as determined by immunoblot
analysis (Fig. 1D, lane C). No signal was detected in the fraction
that includes membranes, mitochondria, and nucleus (Fig. 1D,
lane HMN). By reprobing the same blots with antibodies
against mitochondrial (AIF), cytosolic (ERK1/2), or nuclear (Hi-
stone H1) proteins, fractionation procedure (Fig. 1D) was vali-
dated. To further analyze the cellular distribution of FAIML in
primary cells, we performed immunofluorescence staining of
cortical neurons transiently transfected with FLAG-tagged
FAIML. Confocal microscopy shows a diffuse cytosolic pattern in
the soma that excludes the nucleus (Fig. 1E). Neurite arbors were
also positive (Fig. 1E, inset).We conclude therefore that FAIML is
a cytosolic soluble protein.
To characterize the expression pattern of FAIML during the
development of the CNS, we performed immunohistochemistry
using the FAIML-specific antibody. FAIML-specific antibodies
labeled neurons inmost brain regions through development (Fig.
2). In contrast, sections incubated with preimmune serum did
not exhibit immunostaining (supplemental Fig. 2A–H, available
at www.jneurosci.org as supplementalmaterial). High levels were
detected in the telencephalon (cerebral cortex and hippocampus)
and cerebellum. Some brain regions such as the thalamus, sep-
tum, caudate–putamen, and globus palidus also showed FAIML
immunostaining. No relevant expression of FAIML was found in
axonal tracts in any regions of the forebrain or cerebellum (data
not shown). In the embryonic cerebral cortex, labeled cells were
located in the cortical plate (CP) and in the subplate (SP), corre-
sponding to postmitotic neurons in these layers (Fig. 2A). At P0,
cortical plate neurons maintained FAIML expression; FAIML-
positive cells were also found in the cortical layer V (Fig. 2B). At
P5, the cell bodies and dendrites of layer V cortical neurons ex-
hibited strong FAIML immunostaining (Fig. 2C). At postnatal
and adult stages, many cortical neurons in layers V and II-III
showed FAIML immunolabeling (Fig. 2D,E). In the embryonic
hippocampus, cells in the hippocampal plate expressed FAIML
(data not shown). At postnatal stages, pyramidal neurons in
CA1–3 and some interneurons through all hippocampal layers
expressed FAIML. Weak staining was seen in the granule cells of
the dentate gyrus (Fig. 2F–H). The distribution of FAIML-
positive cells in the hippocampus wasmaintained into adulthood
(data not shown). The cerebellum also showed an intense FAIML
immunolabeling. FAIML was expressed in migratory Purkinje
cells in the embryonic cerebellum (data not shown). At early
postnatal stages (P5), the cell bodies of Purkinje neurons ex-
pressed high levels of FAIML; Purkinje cell dendrites also showed
intense FAIML immunostaining (Fig. 2 I). In addition, at P5 and
P10, some interneurons located in the internal granular layer
were positive for FAIML immunostaining (Fig. 2 J,K). Purkinje
neurons and some cerebellar interneurons maintained the
FAIML expression at later stages and also through adulthood (Fig.
2 J–L).
To confirm that FAIML was expressed in neurons, sections
from E16, P5, and adult brains were immunoreacted for FAIML
and distinct neural markers. Double immunolabeling with
FAIML antibodies and the pan-neuronal marker NeuN showed
an almost complete colocalization of both proteins at all the de-
velopmental stages tested (Fig. 2M–O). Similarly, double immu-
nolabeling with FAIML antibodies and markers of neuronal sub-
sets (such as calbindin and parvalbumin) (data not shown)
further confirmed that FAIML was expressed in neurons (Fig.
2P–R). Finally, double immunofluorescence studies with cell
markers of astroglial cells (GFAP) (supplemental Fig. 2 I–K, avail-
able at www.jneurosci.org as supplemental material), oligoden-
drocytes (O4) (data not shown), or endothelial cells (CD31)
(supplemental Fig. 2L–N, available at www.jneurosci.org as sup-
plemental material) did not reveal colocalization with FAIML
protein. We conclude that FAIML protein is predominantly ex-
pressed in developing and adult neurons.
FAIML is upregulated during neuronal differentiation
To obtain quantitative expression data, we performed immuno-
blots with cortical tissue lysates of mouse brains from different
ages. FAIML levels were low at E12. A moderate increase was
detected at E15, and maximum levels were reached at E18. Then,
FAIML levels were stabilized in the early postnatal stages and in
the adult (Fig. 3A). However, levels of FAIMS were unaltered
during development. To determine whether FAIML is expressed
in differentiated cells, levels of the protein were analyzed in cul-
tured cells. The expression of FAIML was analyzed in cultures of
cortical neurons. The FAIML signal was low at day 0 (a few hours
after plating) but increased by threefold with time in culture (Fig.
3B). Again, levels of FAIMS were barely detectable and un-
changed during the time course. Next, we analyzed the expres-
sion of FAIM in a well characterized differentiation cellular
model system.As shown in Figure 3C, NGF induces an increase in
FAIML mRNA levels up to threefold in PC12 cells when com-
pared with the untreated proliferating cells. Moreover, FAIML
protein amounts increase approximately threefold (after 1, 3, 5,
or 7 d with the neurotrophin) or sixfold (after 9 d in the presence
of the neurotrophin) compared with proliferating control levels
(Fig. 3D). However, mRNA and protein levels of FAIMS remain
unaltered during the different days in the presence of NGF (Fig.
3C,D).
Because FAIML was upregulated in response to NGF in PC12
cells, we wanted to determine which signaling pathway was in-
volved in this regulation. Because the MAPK/ERK pathway has
been shown to be one of the most relevant for neurotrophin-
induced neuronal differentiation (Chao, 2003), we analyzed its
involvement in FAIML regulation. As shown in Figure 3E, NGF
induces a significant increase in the FAIML protein content com-
pared with the level observed in proliferating PC12 cells. Treat-
ment of cultures with the microtubule-associated protein kinase
kinase (MEK) inhibitor PD98059 blocked the increase of FAIML
after NGF exposure, thus indicating that the MAPK/ERK path-
way was primarily responsible for FAIML induction. To further
investigate the regulation of FAIML transcription, we cloned the
rat FAIMpromoter (2.2 kbp) into the luciferase reporter plasmid
pGL3-basic. There was basal activation of the FAIML reporter
plasmids in PC12 cells without stimulation, probably because of
the fact that PC12 cells express the short form of FAIM. Treat-
ment with NGF further increased luciferase signal. After incuba-
tion with MEK1 inhibitor PD98059, the activity of FAIM pro-
moter was reduced to almost nonstimulated luciferase levels,
further suggesting that the MAPK/ERK-dependent signaling
pathway is the main activator of FAIML transcription in PC12
cells (Fig. 3F). It should be noted that NGF treatment does not
induce an increase in the levels of FAIMS transcription (data not
shown). We could not detect changes in FAIML expression in
NGF-stimulated PC12 cells when the phosphatidyl inositol
3-kinase (PI3K)/Akt or NF-B pathways were blocked with
LY294002 or the peptide SN50, respectively (data not shown).
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FAIML and FAIMS play different roles in the nervous system
Previous work of our laboratory demonstrated that FAIMS over-
expression caused an increase in neurite length induced by NGF,
both in PC12 cells and in SCG neurons, through the activation of
the NF-B pathway. As such, reduction of endogenous FAIMS by
RNAi significantly decreased NGF-stimulated neurite outgrowth
from PC12 cells and SCG neurons (Sole et al., 2004). In contrast,
when forced expression of FAIML was tested in the same assays,
Figure 2. Distribution of FAIML-immunoreactive cells during the development of mice brain. A–E, In the cortex, many neuronal cell bodies show immunohistochemical labeling. A, At E16,
neurons in the CP and SP contain FAIML. B, At P0, some neurons in the incipient layer V are FAIML-positive cells. In postnatal stages, many neuronal cell bodies and dendrites present FAIML-
immunolabeling, mainly in layer V (C, arrows). F–H, In the hippocampus, many pyramidal neurons and hippocampal interneurons express FAIML, and granular neurons in the dentate gyrus (DG)
present weak immunostaining. Some hippocampal interneurons scattered in all hippocampal layers show a strong immunostained signal (F, H, arrows). I–L, In the cerebellum, the soma and
dendrites of Purkinje cells show immunohistochemical staining at all postnatal stages analyzed. Also, some interneurons located in the granular layer (GL) express FAIML (J, arrows). M, N,
Immunofluorescence colocalization (arrows) of FAIML and NeuN proteins in cortical layer V at P5. P–R, Immunofluorescence colocalization of FAIML and calbindin in Purkinje cells (arrows) in the
adult cerebellum. MZ, Marginal zone; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone; CA1–CA3, hippocampal fields; so, stratum oriens; sp, stratum pyramidale; sr, stratum
radiatum; slm, stratum lacunosum-moleculare; sm, stratummoleculare; sg, stratum granulosum; h, hilus; ML, molecular layer; PCL, Purkinje cell layer; GL, granule cell layer. Scale bars: (in A) A, B,
F, J, H, 100m; (in C) C–E, 100m; G, 100m; (in I ) I, K, L, 100m; (inM )M–O, 25m; (in P) P–R, 100m.
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no enhanced neurite outgrowth was observed (data not shown).
However, the effects of endogenous FAIML were not monitored
and the possibility that FAIML might be necessary for neurite
formation was not ruled out. To test this hypothesis, we first
analyzed the effect of FAIML overexpression in the NF-B activ-
ity luciferase reporter assay. As shown in Figure 4A, no increase
in luciferase signal was detected after NGF treatment in FAIML-
transfected cells (1.88 105 0.61 105 vs control cells, 2.88
105 0.69 105). However, a statistically significant increase in
NF-B activity was observed in those transfected with FAIMS
(4.47 105 0.62 105 vs control cells, 2.88 105 0.69
105) even in the absence of NGF (3.00  105  0.09  105 vs
control cells, 1.11  105  0.14  105) (Fig. 4A). To further
confirm that FAIML has no role in neurite outgrowth, we gener-
ated specific short hairpin RNAi (shRNAi) constructs that target
different sites of FAIM sequence, which could knock-down spe-
cifically FAIML or FAIMS. RNAi n° 1 (R1), which targeted exon 2,
efficiently downregulated FAIML as shown in Figure 4B. RNAi n°
2 targeted 19 nucleotides after the differential sequence between
FAIML and FAIMS. This construct minimally affects endogenous
Figure 3. FAIML is upregulated during neuronal differentiation in vitro and in vivo. A, Tem-
poral profile of FAIML expression at the indicated developmental stages. Cortical brain lysates of
different embryos were processed, and immunoblots using anti-FAIML and FAIMS were per-
formed. -Tubulin was used as a loading control. The bottom panel shows quantification of
three independent experiments. B, Immunoblot of FAIML and FAIMS expression in E12 embry-
onic cortical neurons at the indicated timepoints. Thebottompanel represents quantificationof
three different experiments. C, FAIMmRNA expression during NGF-induced PC12 cell differen-
tiationwas also assessed using semiquantitative RT-PCR and comparedwith L27 housekeeping
gene. The graph shows a representative experiment out of three. D, Time course of FAIML and
FAIMS protein expression in PC12 cells subjected to NGF-induced differentiation. As loading
control, membranes were also immunoblotted with an anti-actin antibody. The bottom panel
representsquantificationof threedifferent experiments.E, Immunoblot analysis of FAIML levels
after NGF exposure of PC12 cells with () or without () MEK1 inhibitor PD98059 50M. The
histogram shows the quantification of FAIML levels of three independent experiments. F, PC12
cells were transfected with reporter constructs, pGL3 (empty vector) and pGL3–2.2 kbp, and
incubated as indicated (100 ng/ml NGF; 50M PD98059). Reporter gene activities were mea-
sured 48 h after transfection and after 24 h of treatment. Phospho-ERK1/2 immunoblot was
performed to control the effect of NGF and PD98059 on ERK phosphorylation. NS, Nonstimu-
lated cells. *p 0.05; **p 0.01.
Figure 4. FAIMS and FAIML have different roles in the nervous system. A, PC12 cells stably
transfectedwith empty vector (Neo, N), FLAG-tagged FAIML (L), or FLAG-tagged FAIMS (S)were
transfectedwith 1–2g of the reporter vector for NF-B (HIV-LTR-Luciferase) by electropora-
tion. Cells were stimulated with 100 ng/ml NGF for the indicated times or left untreated (NS,
nonstimulated), and cell lysates were obtained with 50l of Cell Culture Lysis Reagent (Lucif-
erase Assay System Kit; Promega). Aliquots of supernatant were transferred to a standard
96-well plate for protein concentration determination using Protein Dye agent (Bio-Rad) fol-
lowing manufacturer instructions. Luciferase values were normalized to protein concentration
(RLU/g of protein). The bottompanels show the control of the transgene expression byWest-
ern blot using a FLAGantibody.B, Schemeof FAIML- and FAIMS-targeted RNAi design. Positions
for the different RNAi are indicated, R1 is sequence specific for FAIML, and R2 is in the common
sequence and specifically silences the FAIMS (toppanel). PC12 cellswere infectedwithR1, R2, or
RS (scrambled) for 72 h, and the effects on endogenous FAIMS/L expression were analyzed by
Western blot with anti-FAIM antibodies (bottom panel). -Tubulin was used as a loading
control. C, PC12 cells were infected with the lentivirus expressing the RNAi constructs and GFP
for 72 h and then treated with NGF (100 ng/ml) for one additional day. Representative images
(top) show the inhibition of NGF-mediated neuritogenesis induced by the FAIMS-specific RNAi
(R2). Both the scrambled (RS) and FAIML-specific (R1) RNAi sequences resulted in similar NGF-
induced neurite outgrowth as in control NI samples. The histogram shows the neurite length
measurements of the GFP-positive cells and digitally acquired cultures infected with the indi-
cated RNAi. **p 0.01. Scale bar, 100m.
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FAIML but efficiently downregulates FAIMS (Fig. 4B, lane 4). To
analyze the effect of RNAi on neurite length, PC12 cells were
infected with lentivirus carrying the vectors encoding for the dif-
ferent RNAi. After 72 h, the cells were treated with NGF (100
ng/ml) plus 0.5% HS for 1 d, and random pictures were taken in
which the neurite length was measured. PC12 cells transduced
with scrambled RNAi sequence developed neurite arbors identi-
cal to noninfected (NI) cells, indicating
that lentiviral infection does not affect
NGF-induced neurite outgrowth. More-
over, PC12 cells infected with R1 devel-
oped normal neurites indistinguishable
from cells noninfected or infectedwithRS.
As expected, PC12 cells infected with R2
significantly decreased their neurite length
(133  18 m) compared with R1-
infected cells (216 24 m) (Fig. 4C).
FAIML prevents death receptor-induced
apoptosis in PC12 cell and
cortical neurons
Because FAIMS was initially proposed to
be a Fas antagonist (Schneider et al., 1999;
Zhong et al., 2001), we investigated
whether FAIML could have this role in the
nervous system. According to previous
data, FasL (Wu et al., 2004) or TNF
(Mielke and Herdegen, 2002) alone did
not induce cell death in PC12 cells,
whereas in combination with ActD (nM)
they induced 25.85  0.62% of cell death
for FasL and 26.41 0.28% for TNF af-
ter 24 h of treatment, measured by count-
ing the number of apoptotic nuclei after
Hoechst staining (Fig. 5A,B). PC12 cells
that overexpress FAIML are completely re-
sistant to FasL or TNF-induced apopto-
sis compared with control cells (Fig.
5A,B). Because caspase-8 has been de-
fined as an apical caspase in both TNF
and Fas-induced cell death, the cleavage of
the fluorescent peptide substrate z-IETD-
afc specific for caspase-8 was measured
(Fig. 5C). Treating PC12 cells with TNF
or ActD alone did not increase the
IETDase activity, whereas cotreatment
with TNF/ActD significantly enhances
the activity. When the same experiment
was done in PC12 cells overexpressing
FAIML, the IETDase activity was com-
pletely blocked in all conditions, including
cells treated with TNF/ActD. Behavior of
DEVDase activity (indicative of executor
caspases 3/7) was similar to that observed
with the IETDase activity (Fig. 5D). In
most cases, caspase-3 activation led to nu-
clear fragmentation, a well-known hall-
mark of apoptotic cell death. Figure 5E
shows representative micrographs of
Hoechst-stained cell nuclei from FAIML
overexpressing or mock-transfected
(PC12-Neo) PC12 cells treated with
TNF/ActD or untreated. After 24 h of
treatment, nuclei from PC12-Neo cells appear rounded and frag-
mented, displaying a highly compacted chromatin and active
Caspase-3 immunostaining (Fig. 5E, top right panel). In contrast,
PC12-FAIML cells treated with TNF/ActD exhibit normal nu-
clei aspect with homogeneously stained chromatin when com-
pared with untreated cells (Fig. 5E, bottom right and both left
panels). In the sameway, TNF/ActD-induced 3-OHDNAends
Figure 5. FAIML overexpression protects PC12 cells from death receptor-induced cell death. Cell death was measured by
counting condensed nuclei after Hoechst staining. PC12 cells were infected for 72 hwith lentivirus carrying empty vector (Empty)
or FAIML (FAIML ) and then were treated or not (C) with sFasL (100 ng/ml) (FasL) for an additional 24 h (A) or with TNF (100
ng/ml) (TNF) or 24 h (B), alone or in combination with ActD (AD) (1 nM). C, Caspase activation was measured in the cell lysates
after 12 h of the indicated treatments using z-IETD-afc for caspase 8 or in D, Ac-DEVD-afc for caspase-3 activity. Data were
normalizedby respect to untreated scrambled infected cells. Data are referred to the respective controls (n3).E, Representative
active caspase-3 immunofluorescence (in red) images were merged with Hoechst 33258 staining (in blue). Note that the typical
apoptotic nuclear morphology and active caspase-3 staining only appears in empty-vector (Neo) PC12 cells treated with TNF/
ActD. Arrowheads point to apoptotic cells.F, Representative images of TUNEL staining are shown. PC12 cells overexpressing FAIML
(PC12-FAIML), but not those carrying an empty construct (PC12-Neo), were resistant to TNF/ActD treatment. Arrowheads
indicate apoptotic nuclei. Scale bars, 25m.G, Overexpression of FAIMS does not protect against TNF/ActD-induced apoptosis.
Stable PC12 cell lines overexpressing empty vector (Neo), FAIML, or FAIMS were treated and processed as indicated in B. *p
0.05;**p 0.01.
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was only seen in PC12 cells transfected
with the empty construct, because cells
overexpressing FAIML did not exhibit
TUNEL positivity after the same treat-
ment (Fig. 5F). In contrast, when the over-
expression of FAIMS was analyzed in the
same system, no protection against TNF/
ActD-induced apoptosis was observed
(Fig. 5G). Similar results were obtained
using primary cultures of cortical cells. As
observed in PC12 cells, combined treat-
ment with TNF/ActD induced apoptosis
in mouse cortical neurons (Fig. 6A).
Lentiviral-induced overexpression of
FAIML blocked death receptor-induced
cell death, whereas the overexpression of
FAIMS did not alter TNF/ActD-induced
cell death. Accordingly, caspase-8 (Fig.
6B) and caspase-3 (Fig. 6C) activities, as
well as cleaved caspase-3-positive neurons
(Fig. 6D), were more abundant in empty
vector-transduced neurons than in cul-
tures infected with lentiviruses carrying
the FAIML construct. Moreover, as in
PC12 cells, FAIML-transduced cortical
neurons did not display TUNEL positivity
after TNF/ActD treatment (Fig. 6E).
FAIML is an endogenous antagonist of
death receptors
To further investigate the relevance of en-
dogenous FAIML,we used the shRNAi tar-
geting system. PC12 cells were transiently
infected with FAIML RNAi (R1), and apo-
ptotic cell death after death receptor trig-
geringwasmeasured by three different ap-
proaches: Hoechst staining, TUNEL assay,
and immunofluorescence detection of ac-
tive caspase-3. FAIML-knocked-down
PC12 cells acquired significant sensitivity
to TNF-induced cell death without the
need of treating the cells with ActD (Fig.
7A–C). As expected, PC12 cells infected
with the scrambled RNAi sequence (RS)
were resistant to TNF. To investigate the
mechanism of prevention of TNF-
mediated apoptosis by FAIML in PC12
cells, we studied the role of caspases.
Caspase-8 activity increased after TNF
treatment in FAIML-knocked-down PC12
cells (3.73  0.41 vs nontreated cells,
1.52  0.05), whereas no activity was de-
tected in scrambled-infected cells (1.23
0.09 vs nontreated cells, 1.0  0.07) (Fig.
7D). These data confirm that FAIML blocks death receptor-
induced apoptosis at the level of or upstream caspase-8 activa-
tion. To confirm RNAi specificity, we reversed the RNAi (R1)
effects using a construct expressing a silentmutated FAIML (mut-
FAIML). R1 RNAi was not efficient in reducing the levels of mut-
FAIML (Fig. 7E). As shown in Figure 7F, the apoptotic cell death
triggered by TNF in FAIML-knocked-down PC12 cells was al-
most completely reverted when these cells were infected with
viruses carrying themutFAIML expression construct (empty vec-
tor transfected cells, 12.3%  1.22 vs mutFAIML transfected
cells, 5.57% 0.37).
Motoneurons and cortical neurons use FAIML as a
endogenous antagonist of death receptors
To assess the physiological relevance of endogenous FAIML in
primary neuronal cells, we knocked-down FAIML in primary
neuronal cultures. It has been reported that cortical neurons ac-
quire Fas sensitivity over time in culture (Cheema et al., 1999;
Figure 6. FAIML , but not FAIMS , protects cortical neurons against TNF/ActD-induced cell death.A, E15mice cortical neurons
were infectedwith lentiviruses carrying empty vector, FAIMS, or FAIML for 6 d. At 6 DIV, cells were treatedwith ActD, TNF, or the
combination of both. Twenty-four hours later, cell death was quantified counting apoptotic nuclei after Hoechst staining. B, C,
Cortical neuronswere treated as inA, and caspases-8 (B) or -3 (C) activitieswere performed. Datawere normalizedwith respect to
untreated scrambled infected cells. Data are referred to the respective controls (n 3). D, Representative active caspase-3
immunofluorescence (in red) images weremergedwith Hoechst 33258 staining (in blue). Note that the typical apoptotic nuclear
morphology and active caspase-3 staining only appeared in empty vector (Neo) PC12 cells treated with TNF/ActD and the
lentivirus-based overexpression of FAIML blocked the processing of caspase-3. Arrowheads indicate apoptotic nuclei. E, Represen-
tative images of TUNEL staining are shown. Cortical neurons infected with viral particles carrying FAIML construct (Lv-FAIML), but
not those infected with an empty construct (Lv-Empty), were resistant to TNF/ActD treatment. Ctrl, Control. *p 0.05; **p
0.01. Scale bars, 25m.
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Zuliani et al., 2006), whereas they retain resistance to TNF (Eves
et al., 2001; Rickle et al., 2006). R1-infected cortical neurons ac-
quire TNF and enhanced Fas sensitivity as assessed by analysis
of the nuclear chromatin fragmentation after Hoechst staining
[24.84  1.09% for TNF and 23.74  1.09% for Jo2 in R1-
infected cells vs 7.68 0.57% (TNF-treated) and 16.45 1.89
(Jo2-treated) in RS-infected cells] (Fig. 8A,B), TUNEL assay
[33.85  2.70% for TNF and 25.29  1.60% for Jo2 in R1-
infected cells vs 11.04 1.77% (TNF-treated) and 13.29 0.62
(Jo2-treated) in RS-infected cells] (Fig. 8C,D) and trypan blue
exclusion assay (data not shown). To confirm these results in a
well-characterized cellular model where
DRs have been shown to have a relevant
function (Raoul et al., 2002; Demjen et al.,
2004; Raoul et al., 2006; Wen et al., 2006),
we performed a series of comparable ex-
periments using spinal cord motoneu-
rons. Motoneurons infected with the R1
sequence show an increase of apoptotic
cell death compared with the scrambled
infected cells after either Fas or TNFR1 en-
gagement (23.12  4.33% for control
cells; 39.76  4.40% for R1/TNF-treated
cells, and 47.39  4.60% for R1/Fas-
treated cells) (Fig. 8E,F). Altogether,
these results confirm the physiological im-
plication of FAIML in neuronal resistance
against death receptor-triggered apopto-
sis, placing it as a new intracellular player
in the regulation of cellular responses dur-
ing nervous system development.
FAIML, but not FAIMS, interacts with
Fas, and its binding can be displaced
by FADD
Finally, because DR-triggered caspase-8
activation is abrogated in cells overex-
pressing FAIML, we wanted to determine
whether FAIML acts upstream of this
caspase. To this end, we checked whether
FAIML could interact with DRs. As shown
in Figure 9A, Fas constitutively associates
with an exogenously transfected FLAG-
tagged FAIML without stimulation with
FasL. Moreover, the binding of FAIML to
Fas canbe revertedwhen cells are stimulated
with FasL (Fig. 9B). In contrast, FAIMS
failed to coimmunoprecipitate with Fas, ir-
respectively of the presence of FasL in the
culture media (Fig. 9A,B). The interaction
between endogenous FAIML and Fas was
confirmed inPC12cells. The specific immu-
noprecipitation of Fas fromuntreated PC12
cell lysates shows that endogenous FAIML
interacts with this DR. As expected, control
iso-specific immunoglobulin (IgG) failed to
immunoprecipitate Fas and, in conse-
quence, FAIML (Fig. 9C). In the same way,
FAIML was also able to interact with endog-
enous Fas in PC12 cells overexpressing
FAIML (Fig. 9C). To assess whether the
adaptor protein FADD could revert the in-
teraction between FAIML and Fas, we per-
formed combined transfections of FLAG-FAIML with HA-FADD,
Fas, or both. As shown in Figure 9D, the overexpression of FADD
fully prevented the interaction between FAIML and Fas, although
Fas was expressed at high levels (Fig. 9D). These data, together with
the anti-apoptotic role of FAIML, suggest that this protein must
block DR-triggered apoptotic cell death at the level of the DR
complex.
Discussion
Signaling pathways controlling neuronal death and survival are
crucial for the normal development and function of the nervous
Figure 7. Endogenous FAIML protects PC12 cells against TNF-induced cell death.A, PC12 cellswere infectedwith RS or R1 for
72hand thenwere treatedwith TNF100ng/ml for anadditional 24hours. Cell deathwasmeasuredby countingapoptotic nuclei
after Hoechst staining and by TUNEL assay. B, Representative images of the TUNEL assay quantified in A. Arrowheads indicate
apoptotic nuclei. C, Active caspase-3 immunofluorescence. PC12 cells were treated as in A, and images showmerged pictures of
caspase-3 immunofluorescence (red) and Hoechst nuclear staining. Arrowheads indicate apoptotic cells. Scale bars, 25m. D,
IETDase activity of cell lysates after 12 h of treatment with TNF. Data are normalized to nontreated scrambled infected cells. E,
Assessment of the RNAi specificity by overexpressing a silent mutated FAIML. Nucleotides in red indicate mutated sequence of
FAIML corresponding toR1 sequence. In thebottomof the figure,Westernblot analysis confirmed the specificity of R1RNAi against
the nonmutated form of FAIML with respect to the mutated FAIML (mutFAIML). Note that RNAi (R1) was not able to reduce the
levels of FAIML in the cells expressingmutFAIML.F, PC12 cellswere infectedwithR1andemptyvector ormutFAIML.After 72h, cells
were treated with TNF, and cell death was measured 24 h later by Hoechst staining and scoring apoptotic nuclei. *p 0.05.
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system. In contrast to most cell types,
neurons survive for the lifetime of the or-
ganism and therefore need to possess
powerful intracellular mechanisms to an-
tagonize cell death stimuli. FAIML was de-
scribed as a splice variant of FAIM (Zhong
et al., 2001) and has remained without any
defined function. Here, we describe that
FAIML is an antagonist of death receptor-
triggered apoptosis in the nervous system.
FAIML overexpression is able to prevent
the death induced by treating cells with
TNF or FasL plus ActD. Moreover, re-
ducing the endogenous levels of FAIML
with RNA interference constructs sensi-
tizes to DR-induced apoptosis in other-
wise resistant primary neurons.
We reported previously that FAIMS in-
creases neurite outgrowth induced by
neurotrophic factors in cultured neurons
through the increased activation of the
NF-B pathway (Sole et al., 2004). Here,
we report that reduction of FAIML does
not modify the NGF-induced neurite out-
growth in PC12 cells (Fig. 4C). Accord-
ingly, FAIML does not modulate the NGF
activation of the NF-B pathway (Fig.
4A). Additional differences between
FAIM splicing isoforms include that
FAIMS overexpression is unable to pre-
vent the death induced by DR triggering
(Fig. 5G). The final and most relevant dif-
ference between both isoforms is that
FAIML is able to bind nonstimulated Fas,
whereas FAIMS does not (Fig. 9). To-
gether, these results demonstrate that
these molecules have vastly different
functions.
Fas ligand (Bechmann et al., 1999) and
its cognate receptor Fas (Park et al., 1998;
Cheema et al., 1999) are highly expressed
in the nervous system, especially during
development. However, natural mouse
mutations for Fas (lpr) or FasL ( gld) do
not presentmajor defects in the number of
neurons in any of the populations ana-
lyzed (Kovac et al., 2002). In mature adult
neurons, the Fas-FasL system seems to
play an important role during certain
pathological situations. Thus, mice in-
jected with functional antibodies against
FasL, as well as lpr and gld mice show a
significant resistance to stroke in vivo
(Martin-Villalba et al., 1999, 2001; Gra-
ham et al., 2004) and to apoptosis after traumatic spinal cord
injury (Yoshino et al., 2004; Casha et al., 2005). Neutralizing
antibodies to FasL promote regeneration and functional recovery
after spinal cord injury (Demjen et al., 2004; Ackery et al., 2006).
However, neuronal populations, with the exception of immature
motoneurons (Raoul et al., 1999, 2002), show either very limited
apoptosis or complete resistance to Fas-induced cell death in vitro
(Gerhardt et al., 2001; Putcha et al., 2002), even if they express Fas
receptor. These data presume the existence of natural antagonists
of the DRs, and several have been shown to be expressed in the
nervous system. c-FLIP is a widely expressed molecule that me-
diates resistance to DR-induced death in a wide range of cellular
models, including lymphocytes and endothelial cells (Irmler et
al., 1997; Thome et al., 1997; Yeh et al., 2000). In addition, Raoul
et al. (1999) have reported that c-FLIP could be responsible for
the resistance to DR-triggered cell death in embryonic motoneu-
rons. Although the anti-apoptotic role of FLIP is well established,
its implication as aDR antagonist in neurons is not conclusive. In
Figure 8. Endogenous FAIML , but not FAIMS , is responsible for the resistance of primary neurons to DR activation. A, E15
cortical neuronswere infectedwith R1, R2, or RS for 72 hbefore Fas-Jo2 (5g/ml) and TNF (100 ng/ml) treatment. Twenty-four
hours later, apoptotic cell deathwas determinedby scoring the percentage of apoptotic cells after Hoechst staining.B, E15 cortical
neuronswere treatedas inA. Twenty-four hours later, active caspase-3wasdetectedby immunofluorescence. Images showactive
caspase-3 immunofluorescence (red)mergedwithHoechst staining.C, E15 cortical neuronswere infectedand treatedas indicated
in A. Then, apoptosis was assessed by the TUNEL assay. D, Representative images of C. E, E12.5 mice motoneurons were infected
with lentiviruses for 5 d. Then, cells were treated with Fas-Jo2 (1g/ml) or TNF (100 ng/ml) for an additional 24 h. Percentage
of cell death was measured by Hoechst staining of nuclei and counting apoptotic profiles. F, Immunofluorescence of active
caspase-3. Images are the result ofmergingHoechst stainingwith active caspase-3 immunofluorescence. Ctrl, Control. *p0.05;
**p 0.01. Scale bars, 25m. Arrowheads indicate apoptotic cells (B, F) and nuclei (D).
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fact, it has been demonstrated that FLIP is not responsible in
mediating Fas-resistance in vitro cultured embryonic neurons
(Beier et al., 2005). Because it has been demonstrated that both
death ligands (DLs) and DRs are expressed during the neuronal
development (Cheema et al., 1999) and in the adult brain (Bette
et al., 2003; Choi and Benveniste, 2004), other intracellular reg-
ulators distinct of FLIP that are able to antagonize DR-mediated
cell death must exist.
Another molecule described as an antagonist of death recep-
tors in the nervous system is LFG (also known as neuronal mem-
brane protein 35, NMP35) (Somia et al., 1999; Schweitzer et al.,
2002; Beier et al., 2005; Ferna´ndez et al., 2007). LFG is predomi-
nantly expressed in the nervous system (Schweitzer et al., 2002)
and has been shown to be the molecule responsible for Fas death
resistance in cerebellar granule neurons (Beier et al., 2005; Fer-
na´ndez et al., 2007).However, a relevant differencewith FAIML is
that LFG is not able to protect from death induced by TNF
(Somia et al., 1999). Whereas expression of FAIML is maximal
during embryonic or early postnatal stages, the expression of LFG
continuously increases during development and reaches maxi-
mal levels in the adult (Schweitzer et al., 2002). This suggests that
LFG could be more significant in neuronal injuries that occur in
the adult.
Neurotrophins exert their anti-apoptotic function by the ac-
tivation of diverse intracellular pathways. One of themainmech-
anisms involved in the cellular resistance to DR-triggered apo-
ptosis is the transcriptional regulation ofDRmodulators (Tran et
al., 2004). In this way, the activation of the MAPK/ERK pathway
suppresses Fas-mediated apoptosis in diverse cellular systems
(Tran et al., 2001). We observed that NGF activates FAIML pro-
moter through the activation of the MAPK/ERK pathway in
PC12 cells. In contrast, LFG is regulated by PI3K-Akt/protein
kinase B (Beier et al., 2005), and c-FLIP is mainly controlled by
NF-B (Okano et al., 2003; Xiao et al., 2003). FAIML expression
was unaffected by the inhibition of these pathways. Neither the
PI3K inhibitor LY294002 nor the p65 SN50 inhibitor for NF-B
modified NGF-regulation of the FAIML promoter in PC12 cells
(data not shown).
Here, we show that the overexpression of FAIML abolishes
DR-induced caspase-8 activation and, therefore, apoptotic cell
death in PC12 cells and in embryonic primary neurons. More-
over, the knock-down of endogenous FAIML sensitizes embry-
onic neurons to apoptosis mediated by DR engagement, in a
caspase-8-dependent manner. Altogether, these data suggest that
the inhibition of DR-induced caspase-8 activation depends on
the levels of anti-apoptotic molecules like FAIML. In Figure 9, we
show that in basal conditions, FAIML, but not FAIMS, is able to
interact with Fas. This interaction is no longer observed when
cells were treated with FasL, therefore suggesting that activation
of the receptor displaces the binding of FAIML. Furthermore, we
show that FADD competes with FAIML for the binding to Fas.
This behavior is similar to what was reported for the silencer of
death domains (SODD) (Jiang et al., 1999; Tschopp et al., 1999).
SODD is a widely expressed protein that is normally associated
with the death domain of TNF-R1 or DR3. When the receptor is
stimulated, SODD is released, permitting the recruitment of
TRADD (TNF receptor-associated death domain) and TRAF2
(TNF receptor-associated factor 2) to the active receptor (Jiang et
al., 1999). However, the mice without SODD develop normally
and do not show any major defects in death receptor signaling,
thus suggesting the existence of other redundant gene (Endres et
al., 2003). Although we have not completely characterized the
mechanisms of FAIML antagonism and FAIML and SODD are
not structurally related, our results favor the view that FAIML
could be a SODD-like molecule specifically expressed in the ner-
vous system.
We reported that FAIML is upregulated during the embryonic
stages whenDLs andDRs like Fas/FasL or TNF-RI andRII/TNF
are expressed in neuronal regions that do not show increased
apoptosis (Nadeau and Rivest, 1999; Kovac et al., 2002). In this
regard, we observe that FAIML upregulation strongly correlates
with the neuronal expression of DRs such as TNF-RI, TNF-RII
(Bette et al., 2003), and Fas (Zuliani et al., 2006). For instance, Fas
is expressed at E15 and its levels are maintained until early post-
natal stages. FAIML and Fas share similar expression patterns that
are particularly strong in the hippocampus, cerebellum, and cor-
tical layers II-III and V of the neocortex, specially in pyramidal
Figure 9. FAIML associates with Fas. A, HEK293T cells were transiently transfected with
pEYFP (Y), pcDNA3-FAIML–FLAG (L), or pcDNA3-FAIMS–FLAG (S). After 24 h, lysates were per-
formed and subjected to immunoprecipitation using FLAG-specific mAb M2-coupled agarose
beads (Sigma). The immunoprecipitates (eluted fractions) were resolved by SDS-PAGE, and
proteins were transferred onto PVDF membranes and immunoblotted with anti-Fas (top pan-
els) or anti-FLAG (M2) (bottompanel) antibodies. Allmembraneswere also stainedwith Naph-
tol Blue to confirm equal loading (middle panels).B, HEK293T cells transfected as inAwere left
untreated or treatedwith soluble FasL (sFasL).Western blotswere performed as stated forA. C,
One milligram of PC12 cell lysate was immunoprecipitated (IP) with anti-Fas antibody (Fas)
followed by Western blot with either FAIML (top panels) or Fas (bottom panels) antibodies. A
nonrelevant iso-specific antibody (IgG) was used as a negative control. D, PC12 cells were
transiently transfected with different constructions carrying FLAG-FAIML, FLAG-FAIMS, HA-
FADD, and/or pcDNA3-mFas (Fas). After 48 h, immunoprecipitation and Western blot analysis
were performed as in A. Blotting the membranes with anti-HA confirmed the PC12 cells trans-
fection with the HA-FADD construct. When FADD was overexpressed, there was no longer any
interaction between FAIML and Fas.
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neurons (Zuliani et al., 2006).We also demonstrate that FAIML is
a powerful inhibitor of apoptosis mediated by the activation of
DRs such as Fas andTNF-Rs. Therefore, we can argue that FAIML
could be a key modulator of DR-triggered apoptosis during de-
velopment of different embryonic neuronal populations of the
CNS.
Other functions have been proposed for the expression of the
Fas-FasL system during development of the nervous system.
Thus, for example, Fas engagement has been shown to induce
neurite outgrowth in dorsal root ganglion neurons in vitro and
promote the functional recovery in vivo of transacted sciatic
nerves (Desbarats et al., 2003). Similarly, the Fas-FasL system has
been involved in controlling neuronal branching, and, impor-
tantly, both lpr and gld mice show reduced dendritic branching
during development (Zuliani et al., 2006). These effects are
caspase independent. Because FAIML does not regulate classical
survival/differentiation pathways such as PI-3K, NF-B, or ERK/
MAPK activated by neurotrophins, it is tempting to speculate
that the anti-apoptotic function of FAIML may act as a critical
switch on the biological consequences derived from DR trigger-
ing, overriding the apoptotic death cascades.
In summary, we provide, for the first time, the involvement of
the splice variant of the anti-apoptotic protein FAIM in the reg-
ulation of DR-triggered neuronal death. FAIML overexpression
blocks DR-induced cell death, and the endogenous protein is
required for neuronal resistance against DR-mediated apoptosis.
This mode of action strictly depends on the inhibition of apical
caspases, like caspase-8, at the level of the receptor complex.
References
Ackery A, Robins S, Fehlings MG (2006) Inhibition of Fas-mediated apo-
ptosis through administration of soluble Fas receptor improves func-
tional outcome and reduces posttraumatic axonal degeneration after
acute spinal cord injury. J Neurotrauma 23:604–616.
Arce V, Pollock RA, Philippe JM, Pennica D, Henderson CE, deLapeyriere O
(1998) Synergistic effects of Schwann- and muscle-derived factors on
motoneuron survival involve GDNF and cardiotrophin-1 (CT-1). J Neu-
rosci 18:1440–1448.
Bayascas JR, Yuste VJ, Sole C, Sanchez-Lopez I, SeguraMF, Perera R, Comella
JX (2004) Characterization of splice variants of human caspase-
activated DNase with CIDE-N structure and function. FEBS Lett
566:234–240.
Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F (1999) FasL
(CD95L, Apo1L) is expressed in the normal rat and human brain: evi-
dence for the existence of an immunological brain barrier. Glia 27:62–74.
Beier CP,Wischhusen J, GleichmannM,Gerhardt E, Pekanovic A, Krueger A,
Taylor V, Suter U, Krammer PH, Endres M, Weller M, Schulz JB (2005)
FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidyl-
inositol 3-kinase-Akt/protein kinase B-dependent expression of life-
guard/neuronal membrane protein 35. J Neurosci 25:6765–6774.
Bette M, Kaut O, Schafer MK, Weihe E (2003) Constitutive expression of
p55TNFR mRNA and mitogen-specific up-regulation of TNF alpha and
p75TNFR mRNA in mouse brain. J Comp Neurol 465:417–430.
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D
(1995) A novel protein that interacts with the death domain of Fas/APO1
contains a sequence motif related to the death domain. J Biol Chem
270:7795–7798.
Casha S, Yu WR, Fehlings MG (2005) Fas deficiency reduces apoptosis,
spares axons and improves function after spinal cord injury. Exp Neurol
196:390–400.
Chao MV (2003) Neurotrophins and their receptors: a convergence point
for many signalling pathways. Nat Rev Neurosci 4:299–309.
Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC (1999)
Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cere-
bral cortex: induction of caspase-dependent cell death and activation of
NF-B. J Neurosci 19:1754–1770.
Choi C, Benveniste EN (2004) Fas ligand/Fas system in the brain: regulator
of immune and apoptotic responses. Brain Res Brain Res Rev 44:65–81.
Comella JX, Sanz-Rodriguez C, Aldea M, Esquerda JE (1994) Skeletal
muscle-derived trophic factors prevent motoneurons from entering an
active cell death program in vitro. J Neurosci 14:2674–2686.
Cullen BR (1987) Use of eukaryotic expression technology in the functional
analysis of cloned genes. Methods Enzymol 152:684–704.
Demjen D, Klussmann S, Kleber S, Zuliani C, Stieltjes B, Metzger C, Hirt UA,
Walczak H, Falk W, Essig M, Edler L, Krammer PH, Martin-Villalba A
(2004) Neutralization of CD95 ligand promotes regeneration and func-
tional recovery after spinal cord injury. Nat Med 10:389–395.
Desagher S, Martinou JC (2000) Mitochondria as the central control point
of apoptosis. Trends Cell Biol 10:369–377.
Desbarats J, Birge RB,Mimouni-RongyM,WeinsteinDE, Palerme JS, Newell
MK (2003) Fas engagement induces neurite growth through ERK acti-
vation and p35 upregulation. Nat Cell Biol 5:118–125.
Endres R, Hacker G, Brosch I, Pfeffer K (2003) Apparently normal tumor
necrosis factor 1 signaling in the absence of the silencer of death domains.
Mol Cell Biol 23:6609–6617.
Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR (2001) FGF in-
duces a switch in death receptor pathways in neuronal cells. J Neurosci
21:4996–5006.
Ferna´ndez M, Segura MF, Sole C, Colino A, Comella JX, Cen˜a V (2007)
Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated
apoptosis in neurons via microdomain recruitment. J Neurochem
103:190–203.
Gerhardt E, Kugler S, Leist M, Beier C, Berliocchi L, Volbracht C, Weller M,
Bahr M, Nicotera P, Schulz JB (2001) Cascade of caspase activation in
potassium-deprived cerebellar granule neurons: targets for treatment
with peptide and protein inhibitors of apoptosis. Mol Cell Neurosci
17:717–731.
Graham EM, Sheldon RA, Flock DL, Ferriero DM,Martin LJ, O’Riordan DP,
Northington FJ (2004) Neonatal mice lacking functional Fas death re-
ceptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis
17:89–98.
Harlow DL (1988) Antibodies: a laboratory manual. Cold Spring Harbor,
New York: Cold Spring Harbor Laboratory.
Iglesias M, Segura MF, Comella JX, Olmos G (2003) Mu-opioid receptor
activation prevents apoptosis following serum withdrawal in differenti-
ated SH-SY5Y cells and cortical neurons via phosphatidylinositol
3-kinase. Neuropharmacology 44:482–492.
IrmlerM, ThomeM, HahneM, Schneider P, Hofmann K, Steiner V, Bodmer
JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J
(1997) Inhibition of death receptor signals by cellular FLIP. Nature
388:190–195.
Jiang Y, Woronicz JD, Goeddel DV (1999) Prevention of constitutive TNF
receptor 1 signaling by silencer of death domains. Science 283:543–546.
Kovac AD, Grammig J, Mahlo J, Steiner B, Roth K, Nitsch R, Bechmann I
(2002) Comparison of neuronal density and subfield sizes in the hip-
pocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondefi-
cient mice. Eur J Neurosci 16:159–163.
Liston P, Young SS, Mackenzie AE, Korneluk RG (1997) Life and death
decisions: the role of the IAPs in modulating programmed cell death.
Apoptosis 2:423–441.
Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL (2004) Tumor
necrosis factor (TNF)-mediated neuroprotection against glutamate-
induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor ac-
tivation. Essential role of a TNF receptor 2-mediated phosphatidylinosi-
tol 3-kinase-dependent NF-kappa B pathway. J Biol Chem
279:32869–32881.
Martin-Villalba A, Herr I, Jeremias I, HahneM, Brandt R, Vogel J, Schenkel J,
Herdegen T, Debatin KM (1999) CD95 ligand (Fas-L/APO-1L) and tu-
mor necrosis factor-related apoptosis-inducing ligandmediate ischemia-
induced apoptosis in neurons. J Neurosci 19:3809–3817.
Martin-Villalba A, HahneM, Kleber S, Vogel J, FalkW, Schenkel J, Krammer
PH (2001) Therapeutic neutralization of CD95-ligand and TNF attenu-
ates brain damage in stroke. Cell Death Differ 8:679–686.
Mielke K, Herdegen T (2002) Fatal shift of signal transduction is an integral
part of neuronal differentiation: JNKs realize TNFalpha-mediated apo-
ptosis in neuronlike, but not naive, PC12 cells. Mol Cell Neurosci
20:211–224.
Mobley WC, Schenker A, Shooter EM (1976) Characterization and isola-
tion of proteolytically modified nerve growth factor. Biochemistry
15:5543–5552.
11240 • J. Neurosci., October 17, 2007 • 27(42):11228–11241 Segura et al. • FAIML Is a Death Receptor Antagonist in Neurons
Nadeau S, Rivest S (1999) Regulation of the gene encoding tumor necrosis
factor alpha (TNF-alpha) in the rat brain and pituitary in response in
different models of systemic immune challenge. J Neuropathol Exp Neu-
rol 58:61–77.
Naldini L, Blomer U, Gage FH, Trono D, Verma IM (1996) Efficient trans-
fer, integration, and sustained long-term expression of the transgene in
adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA
93:11382–11388.
NeumannH, Schweigreiter R, Yamashita T, Rosenkranz K,Wekerle H, Barde
YA (2002) Tumor necrosis factor inhibits neurite outgrowth and
branching of hippocampal neurons by a -dependent mechanism. J Neu-
rosci 22:854–862.
Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugi-
moto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T (2003)
Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of
cell death and survival in human hepatocellular carcinoma. Lab Invest
83:1033–1043.
Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, Yonehara S
(1998) Expression of fas antigen in the normal mouse brain. Biochem
Biophys Res Commun 252:623–628.
Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, Johnson Jr
EM (2002) Intrinsic and extrinsic pathway signaling during neuronal
apoptosis: lessons from the analysis of mutant mice. J Cell Biol
157:441–453.
Raoul C, Henderson CE, Pettmann B (1999) Programmed cell death of em-
bryonicmotoneurons triggered through the Fas death receptor. J Cell Biol
147:1049–1062.
Raoul C, Pettmann B, Henderson CE (2000) Active killing of neurons dur-
ing development and following stress: a role for p75(NTR) and Fas? Curr
Opin Neurobiol 10:111–117.
Raoul C, Estevez AG,NishimuneH, ClevelandDW, deLapeyriereO,Hender-
son CE, Haase G, Pettmann B (2002) Motoneuron death triggered by a
specific pathway downstream of Fas potentiation by ALS-linked SOD1
mutations. Neuron 35:1067–1083.
Raoul C, Buhler E, Sadeghi C, Jacquier A, Aebischer P, Pettmann B, Hender-
son CE, Haase G (2006) Chronic activation in presymptomatic amyo-
trophic lateral sclerosis (ALS) mice of a feedback loop involving Fas,
Daxx, and FasL. Proc Natl Acad Sci USA 103:6007–6012.
Rickle A, Behbahani H, Ankarcrona M, Winblad B, Cowburn RF (2006)
PTEN, Akt, and GSK3beta signalling in rat primary cortical neuronal
cultures following tumor necrosis factor-alpha and trans-4-hydroxy-2-
nonenal treatments. J Neurosci Res 84:596–605.
Schneider TJ, Fischer GM, Donohoe TJ, Colarusso TP, Rothstein TL (1999)
A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM)
isolated from inducibly Fas-resistant B lymphocytes. J Exp Med
189:949–956.
Schweitzer B, Suter U, Taylor V (2002) Neural membrane protein 35/Life-
guard is localized at postsynaptic sites and in dendrites. Brain Res Mol
Brain Res 107:47–56.
Shin DH, Lee E, Kim HJ, Kim S, Cho SS, Chang KY, Lee WJ (2002) Fas
ligand mRNA expression in the mouse central nervous system. J Neuro-
immunol 123:50–57.
Sole C, Dolcet X, Segura MF, Gutierrez H, Diaz-Meco MT, Gozzelino R,
Sanchis D, Bayascas JR, Gallego C, Moscat J, Davies AM, Comella JX
(2004) The death receptor antagonist FAIMpromotes neurite outgrowth
by a mechanism that depends on ERK and NF-kappa B signaling. J Cell
Biol 167:479–492.
Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma
IM (1999) LFG: an anti-apoptotic gene that provides protection from
Fas-mediated cell death. Proc Natl Acad Sci USA 96:12667–12672.
ThomeM, Schneider P, HofmannK, Fickenscher H,Meinl E, Neipel F,Matt-
mannC, Burns K, Bodmer JL, SchroterM, Scaffidi C, Krammer PH, Peter
ME, Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent
apoptosis induced by death receptors. Nature 386:517–521.
Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE (2001)
MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL
receptors. J Biol Chem 276:16484–16490.
Tran SE, Meinander A, Eriksson JE (2004) Instant decisions: transcription-
independent control of death-receptor-mediated apoptosis. Trends Bio-
chem Sci 29:601–608.
Tschopp J, Irmler M, Thome M (1998) Inhibition of fas death signals by
FLIPs. Curr Opin Immunol 10:552–558.
Tschopp J, Martinon F, Hofmann K (1999) Apoptosis: silencing the death
receptors. Curr Biol 9:R381–R384.
Ugolini G, Raoul C, Ferri A,Haenggeli C, Yamamoto Y, SalaunD,Henderson
CE, Kato AC, PettmannB,Hueber AO (2003) Fas/tumor necrosis factor
receptor death signaling is required for axotomy-induced death of mo-
toneurons in vivo. J Neurosci 23:8526–8531.
Wen W, Sanelli T, Ge W, Strong W, Strong MJ (2006) Activated microglial
supernatant induced motor neuron cytotoxicity is associated with up-
regulation of the TNFR1 receptor. Neurosci Res 55:87–95.
Wu S, Zhou L, Rose M, Xiao X, Graham SH (2004) c-FLIP-L recombinant
adeno-associated virus vector infection prevents Fas-mediated but not
nerve growth factor withdrawal-mediated cell death in PC12 cells. Brain
Res Mol Brain Res 122:79–87.
Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK (2003) Resistance of human
ovarian cancer cells to tumor necrosis factor alpha is a consequence of
nuclear factor kappaB-mediated induction of Fas-associated death
domain-like interleukin-1beta-converting enzyme-like inhibitory pro-
tein. Endocrinology 144:623–630.
Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N,
Bonnard M, Goeddel DV, Mak TW (2000) Requirement for Casper (c-
FLIP) in regulation of death receptor-induced apoptosis and embryonic
development. Immunity 12:633–642.
Yoshino Q, Matsumo H, Nakamura H, Yudoh K, Abe Y, Sawai T, Uzuki M,
Yonehara S, Kimura T (2004) The role of Fas-mediated apoptosis after
traumatic spinal cord. Spine 29:1394–1404.
Yuste VJ, Bayascas JR, Llecha N, Sanchez-Lopez I, Boix J, Comella JX (2001)
The absence of oligonucleosomal DNA fragmentation during apoptosis
of IMR-5 neuroblastoma cells: disappearance of the caspase-activated
DNase. J Biol Chem 276:22323–22331.
Yuste VJ, Sanchez-Lopez I, Sole C, Moubarak RS, Bayascas JR, Dolcet X,
EncinasM, Susin SA, Comella JX (2005) The contribution of apoptosis-
inducing factor, caspase-activated DNase, and inhibitor of caspase-
activated DNase to the nuclear phenotype and DNA degradation during
apoptosis. J Biol Chem 280:35670–35683.
Zhong X, Schneider TJ, Cabral DS, Donohoe TJ, Rothstein TL (2001) An
alternatively spliced long form of Fas apoptosis inhibitory molecule
(FAIM) with tissue-specific expression in the brain. Mol Immunol
38:65–72.
Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D
(1998) Self-inactivating lentivirus vector for safe and efficient in vivo
gene delivery. J Virol 72:9873–9880.
Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann
N, Martinez A, del Rio JA, Soriano E, Vodrazka P, Kuner R, Groene HJ,
Herr I, Krammer PH, Martin-Villalba A (2006) Control of neuronal
branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ
13:31–40.
Segura et al. • FAIML Is a Death Receptor Antagonist in Neurons J. Neurosci., October 17, 2007 • 27(42):11228–11241 • 11241
